Area of research
Genetics · Cancer Research
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Meningioma and schwannoma management, and Lung Cancer Treatments and Mutations.
Chromosome 1p Loss and 1q Gain for Grading of Meningioma
Digital Pathology–Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma
Comparative pathology boards facilitate the translation of knowledge between canine and human cancer patients
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Development and validation of a molecular classifier of meningiomas
Grade 3 meningioma survival and recurrence outcomes in an international multicenter cohort
Correction to: Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification
EPEN-10. SPINAL EPENDYMOMA WITH MYCN-AMPLIFICATION – A DISEASE OF CHILDHOOD AND YOUNG ADULTHOOD WITH DISMAL PROGNOSIS
Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification
Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas
Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma
MYCN amplification drives an aggressive form of spinal ependymoma
Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
The driver landscape of sporadic chordoma
PDTM-49. GLOBAL REDUCTION IN H3K27me3, SIMILAR TO H3K27M MUTANT GLIOMAS, IS A MOLECULAR SURROGATE FOR PEDIATRIC POSTERIOR FOSSA- GROUP A EPENDYMOMAS
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Deep Sequencing Identifies <i>IDH1</i> R132S Mutation in Adult Medulloblastoma
Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling
Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
Personalizing the Treatment of Pediatric Medulloblastoma: Polo-like Kinase 1 as a Molecular Target in High-Risk Children
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) Low-grade Glioma Research Workshop